SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIZZI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.222
AS - Asia 5.519
EU - Europa 3.318
SA - Sud America 753
AF - Africa 109
Continente sconosciuto - Info sul continente non disponibili 103
OC - Oceania 10
Totale 23.034
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.907
SG - Singapore 2.116
CN - Cina 1.430
DE - Germania 840
VN - Vietnam 616
BR - Brasile 577
UA - Ucraina 518
IT - Italia 450
GB - Regno Unito 401
HK - Hong Kong 378
FI - Finlandia 341
TR - Turchia 327
CA - Canada 195
FR - Francia 189
BD - Bangladesh 157
SE - Svezia 140
RU - Federazione Russa 138
IN - India 122
JP - Giappone 117
MX - Messico 70
PL - Polonia 69
AR - Argentina 47
ZA - Sudafrica 46
NL - Olanda 45
IQ - Iraq 40
BE - Belgio 39
ES - Italia 39
PK - Pakistan 31
CO - Colombia 29
LT - Lituania 29
ID - Indonesia 28
EC - Ecuador 26
VE - Venezuela 22
UZ - Uzbekistan 21
SA - Arabia Saudita 19
MA - Marocco 18
AE - Emirati Arabi Uniti 17
MY - Malesia 17
CZ - Repubblica Ceca 16
CL - Cile 14
PH - Filippine 14
JM - Giamaica 12
PY - Paraguay 12
TN - Tunisia 11
PE - Perù 10
AT - Austria 9
NP - Nepal 9
UY - Uruguay 9
AU - Australia 8
EG - Egitto 8
IL - Israele 8
CH - Svizzera 7
HN - Honduras 7
IR - Iran 7
JO - Giordania 7
CR - Costa Rica 6
DO - Repubblica Dominicana 6
IE - Irlanda 6
KE - Kenya 6
AL - Albania 5
BG - Bulgaria 5
BO - Bolivia 5
GR - Grecia 5
KR - Corea 5
KZ - Kazakistan 5
RO - Romania 5
TT - Trinidad e Tobago 5
ET - Etiopia 4
HR - Croazia 4
SN - Senegal 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BH - Bahrain 3
DZ - Algeria 3
LB - Libano 3
NO - Norvegia 3
PA - Panama 3
SV - El Salvador 3
AM - Armenia 2
BB - Barbados 2
BJ - Benin 2
CY - Cipro 2
DK - Danimarca 2
GD - Grenada 2
KH - Cambogia 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
SR - Suriname 2
AI - Anguilla 1
BF - Burkina Faso 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CV - Capo Verde 1
GA - Gabon 1
GE - Georgia 1
Totale 22.917
Salva come PNG Salva come JPEG
Città #
Ashburn 1.656
Singapore 1.408
Fairfield 1.156
Woodbridge 1.108
San Jose 771
Houston 679
Jacksonville 577
Ann Arbor 564
Chandler 513
Santa Clara 475
Seattle 455
Beijing 454
Wilmington 411
Cambridge 379
Hong Kong 373
Munich 340
Dallas 298
Los Angeles 278
New York 266
Council Bluffs 217
Ho Chi Minh City 204
Izmir 185
Helsinki 155
Nanjing 154
Milan 141
Hanoi 134
Princeton 114
Tokyo 113
San Diego 103
Boardman 100
Lauterbourg 97
Shanghai 91
Orem 80
Denver 77
São Paulo 73
Turku 72
Brooklyn 71
London 67
Atlanta 63
Montreal 63
Ferrara 61
Nanchang 61
Warsaw 58
Dearborn 55
Toronto 54
Phoenix 51
Chicago 49
Shenyang 47
Frankfurt am Main 46
Buffalo 45
San Francisco 44
Boston 39
Mexico City 39
Brussels 37
Hebei 35
Bremen 34
Falkenstein 33
Tianjin 33
Chennai 30
Da Nang 29
Hefei 29
Johannesburg 27
Manchester 26
Auburn Hills 25
Haiphong 25
Stockholm 25
Jiaxing 24
Mountain View 24
San Mateo 24
Philadelphia 23
Rio de Janeiro 23
Falls Church 22
Mcallen 22
The Dalles 22
Dhaka 21
Norwalk 21
Tashkent 20
Amsterdam 19
Changsha 19
Mumbai 19
Baghdad 18
Jinan 18
Moscow 18
Bologna 17
Montréal 17
Zhengzhou 17
Addison 16
Poplar 16
Secaucus 16
Redwood City 15
Calgary 14
Kunming 14
Lahore 14
Rome 14
Guangzhou 13
Jeddah 13
Tappahannock 13
Washington 13
Belo Horizonte 12
Hải Dương 12
Totale 16.175
Salva come PNG Salva come JPEG
Nome #
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 1.253
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 401
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 326
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 300
Effects of vasoactive agents in healthy and diseased human saphenous veins 283
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 283
A new selective antagonist of the nociceptin receptor 282
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 277
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 276
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 273
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 272
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 268
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 268
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 264
A new ligand for the urotensin II receptor 261
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 260
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 248
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 246
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 245
Ala scan analogues of HOE 140. Synthesis and biological activities 244
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 241
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 241
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 240
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 234
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 233
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 233
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 232
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 230
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 226
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 224
Pharmacological characterisation of novel kinin B2 receptor ligands 224
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 224
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 223
Pharmacological characterization of tachykinin tetrabranched derivatives 222
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 221
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 220
B1 and B2 kinin receptors in various species 218
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 218
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 215
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 215
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 213
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 211
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 211
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 209
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 208
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 208
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 208
Pharmacological characterization of nociceptin receptor: an in vitro study 208
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 206
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 205
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 204
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 203
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 202
Structure-activity study at positions 3 and 4 of human neuropeptide S. 200
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 200
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 197
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 192
Characterization of the human vascular kinin B2 receptor by binding assays. 191
Anxiolytic-like effect of neuropeptide S in the rat defensive burying 191
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 190
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 186
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 186
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 186
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 184
Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: An in vitro study on human, rabbit and pig vascular B2 receptors 183
Nociceptin/orphanin FQ receptor ligands 183
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 181
Structure-activity relationship study on human urotensin II 181
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 175
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 174
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 171
Pharmacology of nociceptin and its receptor: a novel therapeutic target 171
In vitro pharmacological profile of peptide III-BTD: A novel ligand for nociceptin/orphanin FQ and opioid receptors 171
Characterization of endothelin receptors in the human umbilical artery and vein 168
In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol 167
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 165
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 165
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 163
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 163
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 161
Pharmacology of the Kallikrein-Kinin system 161
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery 159
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 158
Receptors for kinins in the human isolated umbilical vein 157
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes 156
Endogenous nociceptin signaling and stress-induced analgesia 155
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 155
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 153
Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor 151
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 150
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 150
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 147
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 145
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 144
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 140
Pharmacological characterization of the nociceptin receptors in the mouse: receptor binding, bioassay and behavioral studies 139
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 136
Characterization of the human vascular kinin B2 receptor by binding assays 134
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 126
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues 2. In vivo studies 125
Totale 21.546
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.963
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.047 0 0 98 81 65 48 64 80 50 104 112 345
2022/20231.252 119 58 58 162 211 169 97 106 162 5 61 44
2023/2024646 73 82 30 16 35 131 24 57 9 12 21 156
2024/20252.838 67 70 209 108 326 315 126 171 418 239 430 359
2025/20267.583 849 329 619 1.013 1.132 476 892 377 707 719 320 150
2026/20271.864 1.285 399 180 0 0 0 0 0 0 0 0 0
Totale 23.034